Revolutionary Treatment for Early-Stage Alzheimer’s Disease at Rambam
July 9, 2024 – A recent revolutionary change in the guidelines for diagnosing Alzheimer’s disease and the new drugs for its treatment are shifting outcomes for patients in the early stages of the disease. Professor David Tanne, director of the Stroke and Cognition Institute at Rambam Health Care Campus (Rambam) in Haifa, Israel, and outgoing…